[144] Fabrinet SEC Filing

Rhea-AI Filing Summary

Filer submitted a Form 144 reporting proposed sales of 13,000 ordinary shares of Fabrinet (FN) through Citigroup Global Markets, with an aggregate market value of $4,568,200.00 and an approximate sale date of 08/28/2025. The filing states these shares were acquired on 08/28/2025 via restricted stock vesting from Fabrinet and were issued as payment for services rendered. The filing also discloses a prior sale by the same account of 10,000 shares on 08/25/2025 generating $3,106,786.92 in gross proceeds. The filer certifies they possess no undisclosed material adverse information.

Positive

• Form 144 discloses proposed insider sale of 13,000 shares with an aggregate market value of $4,568,200.00, providing regulatory transparency
• Sale routed through a major broker, Citigroup Global Markets, Inc., supporting orderly market execution
• Filing specifies acquisition method as restricted stock vesting and payment as services rendered, clarifying compensation context

Negative

• The filer executed a recent sale of 10,000 shares on 08/25/2025 for $3,106,786.92, and is proposing an additional 13,000-share sale days later, representing notable insider liquidity
• The shares to be sold were acquired and listed for sale on the same date (08/28/2025), which may be perceived as immediate monetization of vested compensation

Insights

Securities Analyst

TL;DR: Insider disclosed planned sales totaling 23,000 shares within days, representing multi-million dollar transactions.

The Form 144 shows the proposed sale of 13,000 shares (value $4.57M) on 08/28/2025 and a recent sale of 10,000 shares on 08/25/2025 (proceeds $3.11M). These are disclosed under Rule 144 and routed through a major broker, Citigroup Global Markets, which supports orderly execution. For investors, the key facts are timing, amounts, and that the securities were acquired via restricted stock vesting and tied to services rendered. The filing complies with Rule 144 notice requirements and includes the filers representation about material information.

Corporate Governance Expert

TL;DR: Disclosure is timely and complete for Rule 144, showing compensation-related vesting and subsequent sales.

The document indicates the 13,000 shares being offered were acquired the same day they are listed for sale, reflecting restricted stock vesting tied to services. The proximity of acquisition and sale, plus a recent 10,000-share sale, is governance-relevant: it documents insider liquidity activity and compensation realization. The filers signed attestation that no undisclosed material adverse information exists is present. No indication is given of a pre-established trading plan or 10b5-1 arrangement in this filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Citigroup Global Markets, Inc. 390 Greenwich St New York NY 10013	13000	4568200.00	35728074	08/28/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	08/28/2025	Restricted Stock Vesting	Fabrinet			13000	08/28/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Csaba Sverha c/o Intertrust Corporate Services One Nexus Way, Camana Bay Grand Cayman E9 KY1-9005	10000	08/25/2025	10000	3106786.92

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the Form 144 for Fabrinet (FN) report?

The filing reports a proposed sale of 13,000 ordinary shares of Fabrinet with an aggregate market value of $4,568,200.00.

When is the proposed sale scheduled under the Form 144?

The approximate date of sale listed is 08/28/2025.

How were the shares to be sold acquired according to the filing?

The 13,000 shares were acquired on 08/28/2025 through restricted stock vesting from Fabrinet and noted as payment for services rendered.

Did the filer report any recent sales prior to this notice?

Yes. The filing discloses a sale of 10,000 shares on 08/25/2025 by the same account, yielding gross proceeds of $3,106,786.92.

Which broker is handling the proposed sale?

The broker named in the filing is Citigroup Global Markets, Inc., 390 Greenwich St, New York, NY 10013.